Higher Atherogenic Index of Plasma Is Associated with Hyperuricemia: A National Longitudinal Study

Table 4

Odds ratio (95% CI) for prevalent hyperuricemia by quartiles of AIP in longitudinal analysis.

Quartiles of AIP	Q1	Q2	Q3	Q4	for trend
Cases	107	114	185	258	—
Prevalence (%)	5.92	6.48	10.37	15.48	—
Model 1	1.00 (reference)	1.10 (0.84–1.45)	1.84 (1.44–2.36)	2.91 (2.30–3.69)	<0.001
Model 2	1.00 (reference)	1.17 (0.86–1.55)	1.95 (1.51–2.52)	3.21 (2.52–4.10)	<0.001
Model 3	1.00 (reference)	1.04 (0.77–1.40)	1.65 (1.25–2.17)	2.58 (1.97–3.38)	<0.001
Model 4	1.00 (reference)	1.01 (0.75–1.37)	1.59 (1.20–2.10)	2.53 (1.93–3.33)	<0.001
Model 5	1.00 (reference)	1.00 (0.74–1.37)	1.59 (1.20–2.11)	2.55 (1.94–3.35)	<0.001

Odds ratio (95% CI) for prevalent hyperuricemia by quartiles of AIP in longitudinal analysis. The adjusting variables were the same as Table 2. ; ; .